DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Nyholm B, Orskov L, Hove K, Gravholt C, Moller N, Alberti K, Moyses C, Kolterman O, Schmitz O.
The amylin analog pramlintide improves glycemic control and reduces postprandial glucagon concentrations in patients with type 1 diabetes mellitus.
Metabolism 1999; 48: 935-941
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.